Exposure to nanographene oxide induces gene expression dysregulation in normal human astrocytes Cover

.blurhash-client-img { display: none !important; }

Exposure to nanographene oxide induces gene expression dysregulation in normal human astrocytes

Endocrine Regulations

Volume 56 (2022): Issue 3 (July 2022)

By: Olha V. Rudnytska, Yuliia V. Kulish, Olena O. Khita, Dmytro O. Minchenko, Dariia O. Tsymbal, Yuliia M. Viletska, Myroslava Y. Sliusar, Dariia D. Trufanova and Oleksandr H. Minchenko

Open Access

|Jul 2022

DOI: https://doi.org/10.2478/enr-2022-0023 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 216 - 226

Published on: Jul 13, 2022

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

nanographene oxide,

mRNA expression,

normal human astrocytes,

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2022 Olha V. Rudnytska, Yuliia V. Kulish, Olena O. Khita, Dmytro O. Minchenko, Dariia O. Tsymbal, Yuliia M. Viletska, Myroslava Y. Sliusar, Dariia D. Trufanova, Oleksandr H. Minchenko, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2022): Issue 3 (July 2022)Next article